The impact of crown-rump length measurement error on combined Down syndrome screening: a simulation study

Ultrasound in Obstetrics and Gynecology

Volumn 33, Issue 5, 2009, Pages 506-511

  Salomon, L J ^a   Bernard, M ^b   Amarsy, R ^b   Bernard, J P ^a   Ville, Y ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Crown rump length; Down syndrome; Error; Nuchal translucency; Quality; Serum markers

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN;

ADULT; ALGORITHM; ANALYTICAL ERROR; ANTIGEN EXPRESSION; ARTICLE; BIOCHEMISTRY; CALCULATION; CASE REPORT; CONTROLLED STUDY; CROWN RUMP LENGTH; DOWN SYNDROME; FEMALE; HEALTH CARE; HUMAN; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL; QUALITY CONTROL; RISK; RISK ASSESSMENT; SCREENING; SECOND TRIMESTER PREGNANCY; SIMULATION; ULTRASOUND;

ADULT; ALGORITHMS; COMPUTER SIMULATION; CROWN-RUMP LENGTH; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; GESTATIONAL AGE; HUMANS; MODELS, THEORETICAL; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 66249120030     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.6371     Document Type: Article

References (36)

1. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a onestop clinic: a review of three years prospective experience. BJOG 2003; 110: 281-286.
2. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G,Wald NJ, D'Alton ME; First- and Second-Trime ter Evaluation of Risk (FASTER) Research Consortium. First-trimester or secondtrimester screening, or both, for Down's syndrome. New Engl J Med 2005; 353: 2001-2011.
3. Spencer K. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review. Br J Obstet Gynaecol 1999; 106: 1287-1293.
4. Nicolaides KH, Sebire NJ, Snijders RJ, Johnson S. Down's syndrome screening in the UK. Lancet 1996; 347: 906-907.
5. Grange G, Pannier E, Goffinet F, Cabrol D, Zorn JR. Dating biometry during the first trimester: accuracy of an every-day practice. Eur J Obstet Gynecol Reprod Biol 2000; 88: 61-64.
6. Daya S. Accuracy of gestational age estimation by means of fetal crown-rump length measurement. Am J Obstet Gynecol 1993; 168: 903-908.
7. Robinson HP. Sonar measurement of fetal crown-rump length as means of assessing maturity in first trimester of pregnancy. BMJ 1973; 4: 28-31.
8. Robinson HP, Fleming JE. A critical evaluation of sonar "crown-rump length" measurements. Br J Obstet Gynaecol 1975; 82: 702-710.
9. Wisser J, Dirschedl P, Krone S. Estimation of gestational age by transvaginal sonographic measurement of greatest embryonic length in dated human embryos. Ultrasound Obstet Gynecol 1994; 4: 457-462.
10. Rahim RR, Cuckle HS, Sehmi IK, Jones RG. Compromise ultrasound dating policy in maternal serum screening for Down syndrome. Prenat Diagn 2002; 22: 1181-1184.
11. Wald NJ, Cuckle HS, Densem JW, Kennard A, Smith D.Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Br J Obstet Gynaecol 1992; 99: 144-149.
12. Benn PA, Borgida A, Horne D, Briganti S, Collins R, Rodis JF. Down syndrome and neural tube defect screening: the value of using gestational age by ultrasonography. Am J Obstet Gynecol 1997; 176: 1056-1061.
13. Spencer K, Bindra R, Nix AB, Heath V, Nicolaides KH. Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester? Ultrasound Obstet Gynecol 2003; 22: 142-148.
14. Muller F, Thibaud D, Poloce F, Gelineau MC, Bernard M, Brochet C, Millet C, Ŕeal JY, Dommergues M. Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markers. Prenat Diagn 2002; 22: 1036-1039.
15. Serdar MA, TütüncüL, Olgun A, Hasimi A, Ozgurtas T, Erbil MK. The effects of analytical factors on second trimester risk estimations. Int J Gynaecol Obstet 2006; 93: 28-32.
16. Evans MI, Van Decruyes H, Nicolaides KH. Nuchal translucency measurements for first-trimester screening: the 'price' of inaccuracy. Fetal Diagn Ther 2007; 22: 401-404.
17. Fries N, Althuser M, Fontanges M, Talmant C, Jouk PS, Tindel M, Duyme M. Quality control of an image-scoring method for nuchal translucency ultrasonography. Am J Obstet Gynecol 2007; 196: 272.e1-5.
18. Herman A, Maymon R, Dreazen E, Caspi E, Bukovsky I,Weinraub Z. Nuchal translucency audit: a novel image-scoring method. Ultrasound Obstet Gynecol 1998; 12: 398-403.
19. Herman A, Dreazen E, Maymon R, Tovbin Y, Bukovsky I, Weinraub Z. Implementation of nuchal translucency imagescoring method during ongoing audit. Ultrasound Obstet Gynecol 1999; 14: 388-392.
20. Malone FD. Nuchal translucency-based Down syndrome screening: barriers to implementation. Semin Perinatol 2005; 29: 272-276.
21. Snijders RJ, Thom EA, Zachary JM, Platt LD, Greene N, Jackson LG, Sabbagha RE, Filkins K, Silver RK, Hogge WA, Ginsberg NA, Beverly S, Morgan P, Blum K, Chilis P, Hill LM, Hecker J, Wapner RJ. First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique. Ultrasound Obstet Gynecol 2002; 19: 353-359.
22. Ville Y. [How to improve the screening and diagnosis of fetal aneuploidy?] Bull Acad Natl Med 2005; 189: 1773-1784; discussion 1784-1787.
23. Ville Y. 'Ceci n'est pas une echographie': a plea for quality assessment in prenatal ultrasound. Ultrasound Obstet Gynecol 2008; 31: 1-5.
24. Wojdemann KR, Christiansen M, Sundberg K, Larsen SO, Shalmi A, Tabor A. Quality assessment in prospective nuchal translucency screening for Down syndrome. Ultrasound Obstet Gynecol 2001; 18: 641-644.
25. Muller F, Forestier F, Dingeon B; ABA Study Group. Second trimester trisomy 21 maternal serum marker screening. Results of a countrywide study of 854,902 patients. Prenat Diagn 2002; 22: 925-929.
26. Salomon LJ, Nasr B, Benoist G, Bouhanna P, Bernard JP, Ville Y. OP25.10: Intra- and interobserver variability and reproducibility of biparietal diameter and crown rump length for ultrasound dating at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2007; 30: 544.
27. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352: 343-346.
28. Snijders RJ, Nicolaides K. First trimester fetal nuchal translucency. In Ultrasound Markers for Fetal Chromosomal Defects, Nicolaides K (ed). Parthenon Publishing: Carnforth, UK, 1996.
29. Nicolaides KH. First-trimester screening for chromosomal abnormalities. Semin Perinatol 2005; 29: 190-194.
30. Cuckle H. Improved parameters for risk estimation in Down's syndrome screening. Prenat Diagn 1995; 15: 1057-1065.
31. PRISCA Statistical Guidelines Application Sheet. 2004-02-05. ZI001-2.
32. Rozenberg P, Bussieres L, Chevret S, Bernard JP, Malagrida L, Cuckle H, Chabry C, Durand-Zaleski I, Bidat L, Lacroix I, Moulis M, Roger M, Jacquemot MC, Bault JP, Boukobza P, Boccara P, Vialard F, Giudicelli Y, Ville Y. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population. Am J Obstet Gynecol 2006; 195: 1379-1387.
33. Royal College of Obstetricians and Gynaecologists (RCOG). Recommendations arising from the 32nd Study Group: Screening for Down syndrome in the first trimester. In Screening for Down Syndrome in the First Trimester, Grudzinskas JG, Ward RHT (eds). RCOG Press: London. 1997; 353-356.
34. Fuchs KM, Peipert JF. First trimester Down syndrome screening: public health implications. Semin Perinatol 2005; 29: 267-271.
35. Malone FD, D'Alton ME. First-trimester sonographic screening for Down syndrome. Obstet Gynecol 2003; 102: 1066-1079.
36. Rozenberg P, Bussieres L, Senat MV. [Down syndrome screening in France: the worst consensus.] J Gynecol Obstet Biol Reprod (Paris) 2007; 36: 95-103.